Seshadri Neervannan

COO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

TARS

Current role

COO

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Tarsus Pharmaceuticals, Inc. (TARS)	Chief Operating Officer	$547,000	—	$893,961	$895,011	$267,300	$24,900	$2,628,172
2024	Tarsus Pharmaceuticals, Inc. (TARS)	Chief Operating Officer	$527,333	—	$1,168,959	$1,133,398	$311,300	$53,699	$3,194,689
2023	Tarsus Pharmaceuticals, Inc. (TARS)	Chief Operating Officer	$500,000	—	$494,095	$488,623	$246,000	$13,200	$1,741,918
2020	Tarsus Pharmaceuticals, Inc. (TARS)	Ph.D. . Chief Operating Officer	$199,621	$85,248	—	$1,926,633	—	$2,175	$2,213,677

No earnings-call appearances or filed executive changes recorded yet.